NEIL STAHL Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NEIL STAHL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NEIL STAHL. NEIL STAHL is EVP Research and Development in REGENERON PHARMACEUTICALS INC ($REGN).
NEIL STAHL in REGENERON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NEIL STAHL: EVP Research and Development
Holdings: 20,979 shares
Current Value: $7,503,979
Latest Transaction: Dec 11 2020
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NEIL STAHL in REGENERON PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 492.00 | 17,500 | 8,610,000 | 17,500 | |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Grant | A | 0.00 | 1,688 | 0 | 24,715 | 23 K to 24.7 K (+7.33 %) |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 750 | 0 | 20,979 | 21.7 K to 21 K (-3.45 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 13,079 | 680,500 | 25,000 | |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 524.26 | 357 | 187,161 | 11,380 | 11.7 K to 11.4 K (-3.04 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 522.37 | 758 | 395,956 | 11,737 | 12.5 K to 11.7 K (-6.07 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 521.32 | 1,595 | 831,505 | 12,495 | 14.1 K to 12.5 K (-11.32 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 520.43 | 2,096 | 1,090,821 | 14,090 | 16.2 K to 14.1 K (-12.95 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 519.85 | 422 | 219,377 | 16,186 | 16.6 K to 16.2 K (-2.54 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 518.54 | 267 | 138,450 | 16,608 | 16.9 K to 16.6 K (-1.58 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 517.99 | 2 | 1,036 | 16,875 | 16.9 K to 16.9 K (-0.01 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 511.56 | 7,582 | 3,878,648 | 16,877 | 24.5 K to 16.9 K (-31.00 %) |
| Apr 15 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 13,079 | 680,500 | 24,459 | 11.4 K to 24.5 K (+114.93 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 25,000 | 1,300,750 | 38,079 | |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 25,000 | 1,300,750 | 38,079 | |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 468.56 | 31 | 14,525 | 11,380 | 11.4 K to 11.4 K (-0.27 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 465.42 | 227 | 105,650 | 11,411 | 11.6 K to 11.4 K (-1.95 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 464.14 | 126 | 58,482 | 11,638 | 11.8 K to 11.6 K (-1.07 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 463.10 | 123 | 56,961 | 11,764 | 11.9 K to 11.8 K (-1.03 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 462.15 | 1 | 462 | 11,887 | 11.9 K to 11.9 K (-0.01 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 461.24 | 614 | 283,201 | 11,888 | 12.5 K to 11.9 K (-4.91 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 460.34 | 252 | 116,006 | 12,502 | 12.8 K to 12.5 K (-1.98 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 459.47 | 692 | 317,953 | 12,754 | 13.4 K to 12.8 K (-5.15 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 458.59 | 460 | 210,951 | 13,446 | 13.9 K to 13.4 K (-3.31 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 457.27 | 141 | 64,475 | 13,906 | 14 K to 13.9 K (-1.00 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 456.63 | 743 | 339,276 | 14,047 | 14.8 K to 14 K (-5.02 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 455.56 | 2,967 | 1,351,647 | 14,790 | 17.8 K to 14.8 K (-16.71 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 454.58 | 102 | 46,367 | 17,757 | 17.9 K to 17.8 K (-0.57 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 453.45 | 113 | 51,240 | 17,859 | 18 K to 17.9 K (-0.63 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 452.08 | 130 | 58,770 | 17,972 | 18.1 K to 18 K (-0.72 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 451.47 | 233 | 105,193 | 18,102 | 18.3 K to 18.1 K (-1.27 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 450.10 | 125 | 56,263 | 18,335 | 18.5 K to 18.3 K (-0.68 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 449.53 | 236 | 106,089 | 18,460 | 18.7 K to 18.5 K (-1.26 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 448.86 | 240 | 107,726 | 18,696 | 18.9 K to 18.7 K (-1.27 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 445.91 | 120 | 53,509 | 18,936 | 19.1 K to 18.9 K (-0.63 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 444.65 | 490 | 217,879 | 19,056 | 19.5 K to 19.1 K (-2.51 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 443.67 | 264 | 117,129 | 19,546 | 19.8 K to 19.5 K (-1.33 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 440.24 | 395 | 173,895 | 19,810 | 20.2 K to 19.8 K (-1.95 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 439.73 | 231 | 101,578 | 20,205 | 20.4 K to 20.2 K (-1.13 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 438.63 | 256 | 112,289 | 20,436 | 20.7 K to 20.4 K (-1.24 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 437.41 | 480 | 209,957 | 20,692 | 21.2 K to 20.7 K (-2.27 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 436.43 | 348 | 151,878 | 21,172 | 21.5 K to 21.2 K (-1.62 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 435.93 | 209 | 91,109 | 21,520 | 21.7 K to 21.5 K (-0.96 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 451.89 | 14,651 | 6,620,640 | 21,729 | 36.4 K to 21.7 K (-40.27 %) |
| Feb 28 2020 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 25,000 | 1,300,750 | 36,380 | 11.4 K to 36.4 K (+219.68 %) |
| Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
| Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Grant | A | 0.00 | 2,625 | 0 | 11,380 | 8.8 K to 11.4 K (+29.98 %) |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 10,000 | 520,300 | 88,079 | |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 365.41 | 300 | 109,623 | 22,455 | 22.8 K to 22.5 K (-1.32 %) |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 364.20 | 2,284 | 831,833 | 22,755 | 25 K to 22.8 K (-9.12 %) |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 363.58 | 1,422 | 517,011 | 25,039 | 26.5 K to 25 K (-5.37 %) |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 362.75 | 5,994 | 2,174,324 | 26,461 | 32.5 K to 26.5 K (-18.47 %) |
| Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 10,000 | 520,300 | 32,455 | 22.5 K to 32.5 K (+44.53 %) |
| May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 25,000 | 1,300,750 | 98,079 | |
| May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 306.37 | 3,278 | 1,004,281 | 22,450 | 25.7 K to 22.5 K (-12.74 %) |
| May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 305.43 | 6,575 | 2,008,202 | 25,728 | 32.3 K to 25.7 K (-20.35 %) |
| May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 304.20 | 15,147 | 4,607,717 | 32,303 | 47.5 K to 32.3 K (-31.92 %) |
| May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 25,000 | 1,300,750 | 47,450 | 22.5 K to 47.5 K (+111.36 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 381.40 | 20,000 | 7,628,000 | 20,000 | |
| May 25 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 26,736 | 818,924 | 0 | |
| May 25 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 295.09 | 11,407 | 3,366,092 | 31,973 | 43.4 K to 32 K (-26.30 %) |
| May 25 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 293.68 | 15,329 | 4,501,821 | 43,380 | 58.7 K to 43.4 K (-26.11 %) |
| May 25 2018 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 26,736 | 818,924 | 58,709 | 32 K to 58.7 K (+83.62 %) |
| Dec 13 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 378.98 | 50,000 | 18,949,000 | 50,000 | |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 20,000 | 612,600 | 26,736 | |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 541.70 | 100 | 54,170 | 23,950 | 24.1 K to 24 K (-0.42 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 540.04 | 100 | 54,004 | 24,050 | 24.2 K to 24.1 K (-0.41 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 539.36 | 200 | 107,872 | 24,150 | 24.4 K to 24.2 K (-0.82 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 538.39 | 600 | 323,034 | 24,350 | 25 K to 24.4 K (-2.40 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 537.42 | 200 | 107,484 | 24,950 | 25.2 K to 25 K (-0.80 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 536.46 | 800 | 429,168 | 25,150 | 26 K to 25.2 K (-3.08 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 535.37 | 800 | 428,296 | 25,950 | 26.8 K to 26 K (-2.99 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 534.64 | 700 | 374,248 | 26,750 | 27.5 K to 26.8 K (-2.55 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 533.49 | 905 | 482,808 | 27,450 | 28.4 K to 27.5 K (-3.19 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 532.44 | 500 | 266,220 | 28,355 | 28.9 K to 28.4 K (-1.73 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 531.42 | 900 | 478,278 | 28,855 | 29.8 K to 28.9 K (-3.02 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 530.64 | 800 | 424,512 | 29,755 | 30.6 K to 29.8 K (-2.62 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 529.61 | 100 | 52,961 | 30,555 | 30.7 K to 30.6 K (-0.33 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 526.45 | 600 | 315,870 | 30,655 | 31.3 K to 30.7 K (-1.92 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 525.10 | 400 | 210,040 | 31,255 | 31.7 K to 31.3 K (-1.26 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 524.08 | 101 | 52,932 | 31,655 | 31.8 K to 31.7 K (-0.32 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 523.52 | 200 | 104,704 | 31,756 | 32 K to 31.8 K (-0.63 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 522.80 | 200 | 104,560 | 31,956 | 32.2 K to 32 K (-0.62 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 521.70 | 100 | 52,170 | 32,156 | 32.3 K to 32.2 K (-0.31 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 510.02 | 10,493 | 5,351,640 | 32,256 | 42.7 K to 32.3 K (-24.55 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 510.02 | 1,201 | 612,534 | 42,749 | 44 K to 42.7 K (-2.73 %) |
| Jun 23 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 20,000 | 612,600 | 43,950 | 24 K to 44 K (+83.51 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 20,295 | 431,269 | 0 | |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 474.48 | 100 | 47,448 | 23,950 | 24.1 K to 24 K (-0.42 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 472.95 | 100 | 47,295 | 24,050 | 24.2 K to 24.1 K (-0.41 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 471.15 | 100 | 47,115 | 24,150 | 24.3 K to 24.2 K (-0.41 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 470.57 | 2,426 | 1,141,603 | 24,250 | 26.7 K to 24.3 K (-9.09 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 469.53 | 2,212 | 1,038,600 | 26,676 | 28.9 K to 26.7 K (-7.66 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 468.63 | 900 | 421,767 | 28,888 | 29.8 K to 28.9 K (-3.02 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 467.82 | 300 | 140,346 | 29,788 | 30.1 K to 29.8 K (-1.00 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 466.52 | 185 | 86,306 | 30,088 | 30.3 K to 30.1 K (-0.61 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 465.49 | 1,244 | 579,070 | 30,273 | 31.5 K to 30.3 K (-3.95 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 464.69 | 400 | 185,876 | 31,517 | 31.9 K to 31.5 K (-1.25 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 463.91 | 100 | 46,391 | 31,917 | 32 K to 31.9 K (-0.31 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 462.72 | 500 | 231,360 | 32,017 | 32.5 K to 32 K (-1.54 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 475.56 | 10,822 | 5,146,510 | 32,517 | 43.3 K to 32.5 K (-24.97 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 475.56 | 906 | 430,857 | 43,339 | 44.2 K to 43.3 K (-2.05 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 20,295 | 431,269 | 44,245 | 24 K to 44.2 K (+84.74 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 268.40 | 4,527 | 1,215,047 | 0 | |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 145.70 | 6,017 | 876,677 | 0 | |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 483.42 | 200 | 96,684 | 23,950 | 24.2 K to 24 K (-0.83 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 482.56 | 808 | 389,908 | 24,150 | 25 K to 24.2 K (-3.24 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 481.64 | 695 | 334,740 | 24,958 | 25.7 K to 25 K (-2.71 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 480.71 | 309 | 148,539 | 25,653 | 26 K to 25.7 K (-1.19 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 479.00 | 100 | 47,900 | 25,962 | 26.1 K to 26 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 476.52 | 100 | 47,652 | 26,062 | 26.2 K to 26.1 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 475.33 | 100 | 47,533 | 26,162 | 26.3 K to 26.2 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 474.82 | 100 | 47,482 | 26,262 | 26.4 K to 26.3 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 472.10 | 100 | 47,210 | 26,362 | 26.5 K to 26.4 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 470.49 | 100 | 47,049 | 26,462 | 26.6 K to 26.5 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 469.83 | 100 | 46,983 | 26,562 | 26.7 K to 26.6 K (-0.38 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 466.33 | 100 | 46,633 | 26,662 | 26.8 K to 26.7 K (-0.37 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 464.98 | 2,167 | 1,007,612 | 26,762 | 28.9 K to 26.8 K (-7.49 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 464.98 | 1,885 | 876,487 | 28,929 | 30.8 K to 28.9 K (-6.12 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 145.70 | 6,017 | 876,677 | 30,814 | 24.8 K to 30.8 K (+24.27 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 464.98 | 1,068 | 496,599 | 24,797 | 25.9 K to 24.8 K (-4.13 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 464.98 | 2,612 | 1,214,528 | 25,865 | 28.5 K to 25.9 K (-9.17 %) |
| Jun 05 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 268.40 | 4,527 | 1,215,047 | 28,477 | 24 K to 28.5 K (+18.90 %) |
| Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 381.92 | 58,342 | 22,281,977 | 58,342 | |
| Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 7,876 | 0 | 23,950 | 31.8 K to 24 K (-24.75 %) |
| Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,500 | 0 | 40,470 | 42 K to 40.5 K (-3.57 %) |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 555.67 | 68,638 | 38,140,077 | 68,638 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 1,921 | 99,950 | 27,594 | 25.7 K to 27.6 K (+7.48 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 75,000 | 2,297,250 | 46,736 | |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 25,000 | 531,250 | 20,295 | |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.41 | 900 | 507,069 | 22,029 | 22.9 K to 22 K (-3.93 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.31 | 5,607 | 3,152,872 | 22,929 | 28.5 K to 22.9 K (-19.65 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 561.36 | 500 | 280,680 | 28,536 | 29 K to 28.5 K (-1.72 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 560.31 | 3,900 | 2,185,209 | 29,036 | 32.9 K to 29 K (-11.84 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 559.26 | 1,500 | 838,890 | 32,936 | 34.4 K to 32.9 K (-4.36 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 558.37 | 9,694 | 5,412,839 | 34,436 | 44.1 K to 34.4 K (-21.97 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 564.19 | 2,100 | 1,184,799 | 44,130 | 46.2 K to 44.1 K (-4.54 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.43 | 8,345 | 4,701,823 | 46,230 | 54.6 K to 46.2 K (-15.29 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.37 | 9,555 | 5,373,445 | 54,575 | 64.1 K to 54.6 K (-14.90 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 13,312 | 7,556,291 | 64,130 | 77.4 K to 64.1 K (-17.19 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 935 | 530,734 | 77,442 | 78.4 K to 77.4 K (-1.19 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 25,000 | 531,250 | 78,377 | 53.4 K to 78.4 K (+46.84 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 39,605 | 22,480,986 | 53,377 | 93 K to 53.4 K (-42.59 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 4,047 | 2,297,199 | 92,982 | 97 K to 93 K (-4.17 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 75,000 | 2,297,250 | 97,029 | 22 K to 97 K (+340.46 %) |
| Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,000 | 0 | 16,405 | 17.4 K to 16.4 K (-5.75 %) |
Page: 1